Gastric plasma biomarkers and Operative Link for Gastritis Assessment gastritis stage

European Journal of Gastroenterology and Hepatology

Volumn 23, Issue 4, 2011, Pages 302-307

  Daugule, Ilva ^a   Sudraba, Agnese ^a,b   Chiu, Han Mo ^e   Funka, Konrads ^a   Ivanauskas, Audrius ^d   Janciauskas, Dainius ^d   Jonaitis, Laimas ^d   Kiudelis, Gediminas ^d   Tolmanis, Ivars ^c   Vanags, Aigars ^c   Lin, Jaw Town ^e   Kupcinskas, Limas ^d   Leja, Marcis ^a,b,c  

^a UNIVERSITY OF LATVIA   (Latvia)

^b RIGA EAST UNIVERSITY HOSPITAL   (Latvia)

^c Digestive Diseases Centre   (Latvia)

^d LITHUANIAN UNIVERSITY OF HEALTH SCIENCES   (Lithuania)

^e NATIONAL TAIWAN UNIVERSITY HOSPITAL   (Taiwan)

Author keywords

gastric atrophy; gastric biomarkers; Operative Link for Gastritis Assessment gastritis stage

Indexed keywords

GASTRIN 17; PEPSINOGEN I; PEPSINOGEN II;

ADULT; AGED; ARTICLE; BLOOD ANALYSIS; CLINICAL ASSESSMENT TOOL; CONTROLLED STUDY; DISEASE SEVERITY; DYSPEPSIA; FEMALE; GASTRIC MUCOSA ATROPHY; GASTRITIS; GASTROINTESTINAL ENDOSCOPY; HUMAN; HUMAN TISSUE; MAJOR CLINICAL STUDY; MALE; OPERATIVE LINK FOR GASTRITIS ASSESSMENT; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; STOMACH BIOPSY;

ADULT; AGED; AGED, 80 AND OVER; BIOLOGICAL MARKERS; FEMALE; GASTRINS; GASTRITIS, ATROPHIC; HELICOBACTER INFECTIONS; HELICOBACTER PYLORI; HUMANS; MALE; MIDDLE AGED; PEPSINOGEN A; PEPSINOGEN C; PROSPECTIVE STUDIES;

EID: 79954422782     PISSN: 0954691X     EISSN: None     Source Type: Journal    
DOI: 10.1097/MEG.0b013e3283438ac3     Document Type: Article

References (17)

1. Rugge M, Meggio A, Pennelli G, Piscioli F, Giacomelli L, De Pretis G, et al. Gastritis staging in clinical practice: the OLGA staging system. Gut 2007; 56:631-636. (Pubitemid 46662927)
2. Rugge M, Genta RM. Staging gastritis: an international proposal. Gastroenterology 2005; 129:1807-1808.
3. Rugge M, Correa P, Di Mario F, El-Omar E, Fiocca R, Geboes K, et al. OLGA staging for gastritis: a tutorial. Dig Liver Dis 2008; 40:650-658.
4. Sipponen P, Harkonen M, Alanko A, Suovaniemi O. Diagnosis of atrophic gastritis from a serum sample. Clin Lab 2002; 48:505-515. (Pubitemid 35174968)
5. Vaananen H, Vauhkonen M, Helske T, Kaariainen I, Rasmussen M, Tunturi-Hihnala H, et al. Non-endoscopic diagnosis of atrophic gastritis with a blood test. Correlation between gastric histology and serum levels of gastrin-17 and pepsinogen I: a multicentre study. Eur J Gastroenterol Hepatol 2003; 15:885-891. (Pubitemid 36904458)
6. Haj-Sheykholeslami A, Rakhshani N, Amirzargar A, Rafiee R, Shahidi SM, Nikbin B, et al. Serum pepsinogen I, pepsinogen II, and gastrin 17 in relatives of gastric cancer patients: comparative study with type and severity of gastritis. Clin Gastroenterol Hepatol 2008; 6:174-179. (Pubitemid 351172947)
7. Iijima K, Abe Y, Kikuchi R, Koike T, Ohara S, Sipponen P, et al. Serum biomarker tests are useful in delineating between patients with gastric atrophy and normal, healthy stomach. World J Gastroenterol 2009; 15:853-859.
8. Leja M, Kupcinskas L, Funka K, Sudraba A, Jonaitis L, Ivanauskas A, et al. The validity of a biomarker method for indirect detection of gastric mucosal atrophy versus standard histopathology. Dig Dis Sci 2009; 54:2377-2384.
9. Sipponen P, Ranta P, Helske T, Kaariainen I, Maki T, Linnala A, et al. Serum levels of amidated gastrin-17 and pepsinogen I in atrophic gastritis: an observational case-control study. Scand J Gastroenterol 2002; 37:785-791. (Pubitemid 34836814)
10. Storskrubb T, Aro P, Ronkainen J, Sipponen P, Nyhlin H, Talley NJ, et al. Serum biomarkers provide an accurate method for diagnosis of atrophic gastritis in a general population: The Kalixanda Study. Scand J Gastroenterol 2008; 43:1448-1455.
11. Chen CJ, You SL, Lin LH, Hsu WL, Yang YW. Cancer epidemiology and control in Taiwan: a brief review. Jpn J Clin Oncol 2002; 32 (Suppl): S66-S81.
12. Ferlay J, Shin HR, Bray F, Forman D, Mathers C, Parkin DM, et al. Estimates of worldwide burden of cancer in 2008: GLOBOCAN 2008. Int J Cancer 2010. [Epub ahead of print]
13. Jonaitis L, Ivanauskas A, Janciauskas D, Funka K, Sudraba A, Tolmanis I, et al. Precancerous gastric conditions in high Helicobacter pylori prevalence areas: comparison between Eastern European (Lithuanian, Latvian) and Asian (Taiwanese) patients. Medicina (Kaunas) 2007; 43:623-629.
14. Rugge M, de Boni M, Pennelli G, de Bona M, Giacomelli L, Fassan M, et al. Gastritis OLGA-staging and gastric cancer risk: a twelve-year clinicopathological follow-up study. Aliment Pharmacol Ther 2010; 31:1104-1111.
15. Miki K, Urita Y. Using serum pepsinogens wisely in a clinical practice. J Dig Dis 2007; 8:8-14. (Pubitemid 46189204)
16. Sipponen P, Graham DY. Importance of atrophic gastritis in diagnostics and prevention of gastric cancer: application of plasma biomarkers. Scand J Gastroenterol 2007; 42:2-10. (Pubitemid 46033039)
17. Cao Q, Ran ZH, Xiao SD. Screening of atrophic gastritis and gastric cancer by serum pepsinogen, gastrin-17 and Helicobacter pylori immunoglobulin G antibodies. J Dig Dis 2007; 8:15-22. (Pubitemid 46189205)